Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain ; 135(Pt 2): 418-30, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22094538

RESUMO

Central pain below the injury level after spinal cord injury is excruciating, chronic and resistive to treatment. Animal studies suggest that pretreatment may prevent central pain, but to date there are no measures to predict its development. Our aim was to monitor changes in the sensory profile below the lesion prior to the development of below-level central pain in order to search for a parameter that could predict its risk and to further explore its pathophysiology. Thirty patients with spinal cord injury and 27 healthy controls underwent measurement of warm, cold, heat-pain and touch thresholds as well as graphaesthesia, allodynia, hyperpathia and wind-up pain in intact region and in the shin and feet (below level). Patients were tested at 2-4 weeks, 1-2.5 months and 2.5-6 months after the injury or until central pain had developed. At the end of the follow-up, 46% of patients developed below-level central pain. During the testing periods, individuals who eventually developed central pain had higher thermal thresholds than those who did not and displayed high rates of abnormal sensations (allodynia and hyperpathia), which gradually increased with time until central pain developed. Logistic regressions revealed that the best predictor for the risk of below-level central pain was allodynia in the foot in the second testing session with a 77% probability (90.9% confidence). The results suggest that neuronal hyperexcitability, which may develop consequent to damage to spinothalamic tracts, precedes central pain. Furthermore, it appears that below-level central pain develops after a substantial build-up of hyperexcitability. To the best of our knowledge, this is the first systematic report establishing that neuronal hyperexcitability precedes central pain. Predicting the risk for central pain can be utilized to initiate early treatment in order to prevent its development.


Assuntos
Limiar da Dor/fisiologia , Dor/fisiopatologia , Traumatismos da Medula Espinal/fisiopatologia , Adolescente , Adulto , Feminino , Seguimentos , Temperatura Alta , Humanos , Hiperalgesia/etiologia , Hiperalgesia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Neuralgia/etiologia , Neuralgia/fisiopatologia , Dor/etiologia , Medição da Dor , Valor Preditivo dos Testes , Traumatismos da Medula Espinal/complicações
2.
Spine (Phila Pa 1976) ; 34(15): E507-12, 2009 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-19564755

RESUMO

STUDY DESIGN: A retrospective study on patients with chronic nonspecific low back pain (NSLBP). OBJECTIVE: To describe the gait stride characteristics of patients with chronic NSLBP, and to examine the effect of a novel biomechanical device on the gait stride characteristics of these patients. SUMMARY OF BACKGROUND DATA: Patient with NSLBP alters their gait patterns. This is considered a protective mechanism as patients try to avoid extensive hip and spine ranges of motion and minimize forces and moments acting on the body. In addition, there are changes in the neuromuscular control system in patients with LBP that could possibly be attributed to the effects of pain on motor control. METHODS: Nineteen patients underwent a gait test, using an electronic walkway, at baseline and after 12 weeks of treatment. Spatiotemporal parameters were used to identify changes in gait pattern. A novel biomechanical device comprised of 4 modular elements attached to foot-worn platforms was used in the study. The modules are 2 convex shaped biomechanical elements attached to each foot, one is located under the hindfoot region and the other is located under the forefoot region. The device was individually calibrated to each patient. The patients were instructed to walk with the calibrated biomechanical device on a daily basis for a period of 12 weeks. RESULTS: Significant differences were found at baseline and after 12 weeks in normalized velocity (P = 0.03), cadence (P < 0.01), left normalized step length (P = 0.02), right normalized step length (P = 0.02), right swing (P < 0.01), right stance (P < 0.01), left single limb support (P = 0.01), left double limb support (P = 0.02), and right double limb support (P = 0.02). CONCLUSION: Patients with NSLBP treated with the novel biomechanical device for 3 months increased walking speed through longer step length and eliminated asymmetrical differences.


Assuntos
Transtornos Neurológicos da Marcha/terapia , Marcha/fisiologia , Dor Lombar/complicações , Modalidades de Fisioterapia/instrumentação , Adulto , Idoso , Idoso de 80 Anos ou mais , Fenômenos Biomecânicos/fisiologia , Doença Crônica/terapia , Avaliação da Deficiência , Feminino , Pé/fisiologia , Lateralidade Funcional/fisiologia , Transtornos Neurológicos da Marcha/fisiopatologia , Humanos , Perna (Membro)/fisiologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento , Caminhada/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...